ZERO-ORDER RELEASE FORMULATION OF OXPRENOLOL HYDROCHLORIDE WITH SWELLING AND EROSION CONTROL

被引：28

作者：

DEVI, KP ^{[1
]}

RAO, KVR ^{[1
]}

BAVEJA, S ^{[1
]}

FATHI, M ^{[1
]}

ROTH, M ^{[1
]}

机构：

[1] PANJAB UNIV,DEPT PHARMACEUT SCI,CHANDIGARH 160014,INDIA

来源：

PHARMACEUTICAL RESEARCH | 1989年 / 6卷 / 04期

关键词：

D O I：

10.1023/A:1015998424548

中图分类号：

O6 [化学];

学科分类号：

0703 ;

摘要：

引用

页码：313 / 317

页数：5

共 30 条

[11]

BOND JH, 1975, J LAB CLIN MED, V85, P546

[12]

DAVIDSON CL, 1976, TOPICS CARDIOVASCULA, P128

[13]

DAVIS SS, 1986, STP PHARM, V2, P1015

[14]

DEVI KP, 1987, THESIS PANJAB U CHAN

[15]

Doelker E, 1986, HYDROGELS MED PHARM, V2, P115

[16] FORMULATION OF SUSTAINED-RELEASE PROMETHAZINE HYDROCHLORIDE TABLETS USING HYDROXYPROPYLMETHYLCELLULOSE MATRICES [J].

FORD, JL ;

RUBINSTEIN, MH ;

HOGAN, JE .

INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1985, 24 (2-3) :327-338

[17]

FORREST WA, 1978, CLIN THER, V1, P235

[18]

GOLDSTRAW PW, 1978, BR J CLIN PRACTIC S1, V32, P67

[19] A CLINICAL AND PHARMACOKINETIC BASIS FOR THE SELECTION AND USE OF SLOW RELEASE THEOPHYLLINE PRODUCTS [J].

HENDELES, L ;

IAFRATE, RP ;

WEINBERGER, M .

CLINICAL PHARMACOKINETICS, 1984, 9 (02) :95-135

[20]

Hopfenberg H.B., 1976, ACS SYM SER, V33, P26

← 1 2 3 →